Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The debt to assets ratio is N/A as of Tuesday, October 6, 2026.
DEBT TO ASSETS RATIO
N/A
Conexeu Sciences Inc.
Market Cap
$83.49M
Debt to Assets Ratio
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO |
|---|---|---|
| Conexeu Sciences Inc. (CNXU) | $83.49M | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $83.96M | 0.01% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.70M | 0.47% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $84.75M | 0.02% |
| Citius Oncology, Inc. (CTOR)vs › | $81.22M | 0.09% |
| CareCloud, Inc. (CCLD)vs › | $86.69M | 0.58% |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.86M | 0.01% |
| electroCore, Inc. (ECOR)vs › | $91.33M | 0.56% |
| Equillium, Inc. (EQ)vs › | $91.68M | 0.01% |
| Biomea Fusion, Inc. (BMEA)vs › | $93.99M | 0.02% |
Debt/Assets
N/A
Debt/Equity
N/A
Current Ratio
N/A
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
